|
597 NICE offers advice
for secondary prevention of MI All patients
who have had a myocardial infarction (MI) should be offered combination
treatment with an angiotensin-converting enzyme inhibitor, aspirin, a
beta-blocker and a statin, new guidance from the National Institute for
Health and Clinical Excellence sets out
PJ 2007;278:597
Full Text
597 Without regulation Society will
be a new body When the regulatory function is removed from the Royal Pharmaceutical Society and the General Pharmaceutical Council is established, the Society will be a new and different body, the Society's President Hemant Patel said in a statement issued this week. “Freed from the constraints of regulation it can be more responsive to its membership,” he added
PJ 2007;278:597
Full Text
597Society retention fees to rise “substantially” next year The
next increase in annual retention fees will be substantial, Royal Pharmaceutical
Society President Hemant Patel told a branch representatives meeting held at
the Society headquarters last week
PJ 2007;278:597
Full Text
597 Society and NPA call on pharmacists to address
problem of pseudoephedrine misuse Pharmacists are
being called upon by the Royal Pharmaceutical Society and the National Pharmacy
Association to put in place a number of measures that will reduce the potential
for pseudoephedrine- or ephedrine-containing products bought from pharmacies
being used in the manufacture of methamphetamine
PJ 2007;278:597
Full Text
598 GPs report a lack of PCT
support for commissioning GPs are committed to
making practice-based commissioning work but believe that they lack support from
primary care trusts, according to a survey of 257 GPs and practice managers carried
out by the King's Fund and the NHS Alliance
PJ 2007;278:598
Full Text
598 Independents must prepare for EPS to avoid
disadvantage NHS Connecting for Health is advising
independent pharmacies to upgrade their computer systems for release 1 of the
Electronic Prescription Service to ensure they are not disadvantaged for release
2 of the service
PJ 2007;278:598
Full Text
598 Community Pharmacy Framework report published Innovative
practice in community pharmacy is one of the features of the final report on
the Community Pharmacy Framework Collaborative published by the National Prescribing
Centre
PJ 2007;278:598
Full Text
598 NPA calls on pharmacists to demonstrate
cost savings The National Pharmacy Association
has urged pharmacists to contact local primary care organisations and demonstrate
how they can contribute to reducing prescribing costs
PJ 2007;278:598
Full Text
599 NICE guideline issued
on treating fever in under-5s How to assess and
manage young children with a raised temperature is the subject of National Institute
for Health and Clinical Excellence guidance published this week
PJ 2007;278:599
Full Text
599 Home Office plans another update to laws
covering Controlled Drugs Consultation has started
on Home Office proposals to update the Misuse of Drugs Regulations 2001 to reflect
modern practice and implement a proposal arising from the Shipman Inquiry
PJ 2007;278:599
Full Text
599 Pharmacists can tackle health inequalities Community
pharmacists have a crucial role to play in reducing health inequalities, Ivana
Silva, head of pharmaceuticals and professional affairs at the Pharmaceutical
Group of the EU, said at the European Society of Clinical Pharmacy conference
in Edinburgh last week
PJ 2007;278:599
Full Text
599 Workforce planning integral to optimal care Workforce
planning is a major issue and will be integral to promoting health, reducing
health inequalities and delivering the best possible care with the resources
available, the Government has said
PJ 2007;278:599
Full Text
600 MI risk for rosiglitazone
disputed An increased risk of myocardial infarction
for people with diabetes taking rosiglitazone has been identified by the authors
of a meta-analysis published online
PJ 2007;278:600
Full Text
600 Testosterone of use in MS? Treatment
with testosterone may slow brain degeneration in men with relapsing-remitting
multiple sclerosis
PJ 2007;278:600
Full Text
600 Coenzyme Q10 and Parkinson's Although
use of daily 300mg coenzyme Q10 supplements leads to plasma levels sufficient
to exert an intracellular effect in patients with Parkinson's disease, it does
not improve symptoms of the disease when added to standard Parkinson's disease
therapies, a placebo-controlled trial of 131 patients shows
PJ 2007;278:600
Full Text
600 Progress on renal services Recent
improvements to services for people with kidney disease, made as a result of
the National Service Framework for Renal Services, are summarised in a report
published this week by the Department of Health
PJ 2007;278:600
Full Text
601 Pharmacists need to improve
their lobbying of MPs Pharmacists are useless at lobbying, according to Jim Devine, Labour MP for Livingston, West Lothian. He was speaking at a meeting of the Chiltern region of the Royal Pharmaceutical Society entitled “Can pharmacy better influence the political and policy agenda at a local or national level?”, in Westminster this week
PJ 2007;278:601
Full Text
601 New health ministers for Scotland now announced Scotland's
new health ministers have now been announced but it has yet to be decided who
will take the lead on pharmacy
PJ 2007;278:601
Full Text
601 SPGC is now Community Pharmacy Scotland The
Scottish Pharmaceutical General Council's transition to Community Pharmacy Scotland
was completed earlier this month and is highlighted in the organisation's latest
Vision newsletter, which will be sent to pharmacists this week
PJ 2007;278:601
Full Text
601 DoH underlines community pharmacists' public
health role Pharmacists' role in public health
is highlighted in the Department of Health's annual review, published last week
PJ 2007;278:601
Full Text
601 Pharmacist in French Government Roselyne
Bachelot-Narquin, a French pharmacist, has been named minister for health, youth
and sport in France
PJ 2007;278:601
Full Text
601 MHRA to speed up licensing This
year's Medicines and Healthcare products Regulatory Agency business plan says
that the organisation will aim to meet all its licensing time targets by the
fourth quarter
PJ 2007;278:601
Full Text
602 Treatment preferences
shifted by patients' knowledge of drug name Patients'
treatment choices may be influenced by knowing a drug's name despite their initial
decisions being based solely on risks and benefits, according to research published
PJ 2007;278:602
Full Text
602 Support for LHRH agonists for breast cancer Addition
of luteinising-hormone-releasing hormone agonists (such as goserelin) to treatment
regimens for pre-menopausal women with hormone-receptor-positive breast cancer
can reduce the risk of disease recurrence by more than an eighth, a meta-analysis
published claims
PJ 2007;278:602
Full Text
602 NPA supports application fees for pharmacy
contracts Support for Government plans to introduce
fees associated with applications for pharmacy contracts has come from the National
Pharmacy Association
PJ 2007;278:602
Full Text |
The
Pharmaceutical Journal